In 2003, Linden and colleagues examined the effects of a VIP agonist in asthma and found a short, but effective, bronchodilatory effect [120]
Angiogenesis Studies: Angiogenic potential investigated through multiple assays: HUVEC tube formation (network complexity), endothelial migration (cells/field), aortic ring sprouting (sprout length/number), VEGF/VEGFR2 expression (qPCR, Western blot), CAM assay (vessel density)
Also, it strongly counteracts corticosteroid-induced adverse effects (i.e., eventual healing failure (Klicek et al., 2008
Pevec et al., 2010) and worsening, and immunosuppression (Sikiric et al., 2003)
Pentadecapeptide BPC 157 cream improves burn-wound healing and suppresses delayed-type hypersensitivity reactions